Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

FDA Authorizes Florida’s Plan to Import Drugs From Canada

  • Post author:PacConAdmin
  • Post published:January 5, 2024
  • Post category:Uncategorized

The FDA has approved Florida’s plan to import drugs from Canada, making it the first state permitted to do so, after submitting its plan to the FDA in 2020. Source: Drug…

Continue ReadingFDA Authorizes Florida’s Plan to Import Drugs From Canada

Novo Nordisk Inks Two New Research Collaborations, Each Worth Up To $532M

  • Post author:PacConAdmin
  • Post published:January 4, 2024
  • Post category:Uncategorized

In an effort to stay dominant in the burgeoning obesity market and expand in the liver disease space, Novo Nordisk has forged two new research partnerships, each potentially worth up…

Continue ReadingNovo Nordisk Inks Two New Research Collaborations, Each Worth Up To $532M

Lilly Launches Direct-to-Consumer Program for Diabetes, Migraine, Weight-Loss Drugs

  • Post author:PacConAdmin
  • Post published:January 4, 2024
  • Post category:Uncategorized

In a move that sidesteps pharmacy benefit managers, Eli Lilly has launched a direct-to-consumer marketing program that will provide several of the company’s medicines for obesity, migraine, and diabetes at…

Continue ReadingLilly Launches Direct-to-Consumer Program for Diabetes, Migraine, Weight-Loss Drugs

Synovo’s Modified Total Hip System Not Cleared, Not to Be Used, FDA Says

  • Post author:PacConAdmin
  • Post published:January 4, 2024
  • Post category:Uncategorized

The FDA has issued a warning to patients and health care providers to not use the Synovo Total Hip System including resurfacing implants, manufactured by Synovo Production after 2019, because…

Continue ReadingSynovo’s Modified Total Hip System Not Cleared, Not to Be Used, FDA Says

Physician Congressman Writes to Califf, Urging Advancement of AI Rules

  • Post author:PacConAdmin
  • Post published:January 4, 2024
  • Post category:Uncategorized

Encouraging the FDA to put in place rules that govern the use of AI in healthcare is the focus of a letter Rep. Greg Murphy (R-N.C.) has sent to FDA…

Continue ReadingPhysician Congressman Writes to Califf, Urging Advancement of AI Rules

Quick Notes — Jan. 3, 2024

  • Post author:PacConAdmin
  • Post published:January 3, 2024
  • Post category:Uncategorized

This edition of Quick Notes looks at recent FDA medical device clearances and designations for EndoSound, EndoQuest Robotics, Perfuze, AnX Robotics, CGBio. Source: Drug Industry Daily

Continue ReadingQuick Notes — Jan. 3, 2024

Court Finds Corcept Therapeutics’ Patents Not Infringed by Teva

  • Post author:PacConAdmin
  • Post published:January 3, 2024
  • Post category:Uncategorized

A New Jersey judge ruled last week that Teva Pharmaceuticals did not infringe on two Corcept patents for its Cushing’s syndrome drug Korlym (mifepristone). Source: Drug Industry Daily

Continue ReadingCourt Finds Corcept Therapeutics’ Patents Not Infringed by Teva

FTC Wins Temporary Injunction, Halting IQVIA-Propel Merger

  • Post author:PacConAdmin
  • Post published:January 3, 2024
  • Post category:Uncategorized

The FTC won its motion to temporarily block IQVIA’s planned purchase of California health advertising firm Propel Media, deeming further review by the commission would be in the public interest.…

Continue ReadingFTC Wins Temporary Injunction, Halting IQVIA-Propel Merger

CDRH Switches From Paper to Electronic for Export Documents

  • Post author:PacConAdmin
  • Post published:January 3, 2024
  • Post category:Uncategorized

CDRH is now issuing electronic export documents for medical devices instead of paper to improve efficiency, reduce the amount of time it takes for a manufacturer to receive export documents,…

Continue ReadingCDRH Switches From Paper to Electronic for Export Documents

Quick Notes — Jan. 2, 2024

  • Post author:PacConAdmin
  • Post published:January 2, 2024
  • Post category:Uncategorized

This edition of Quick Notes looks at recent M&As involving Bristol Myers Squibb, Novartis and Roche. Source: Drug Industry Daily

Continue ReadingQuick Notes — Jan. 2, 2024
  • Go to the previous page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • …
  • 143
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company